Product image of Neotigason (Acitretin) supplied by GNH India

Neotigason

Active Ingredient:
Acitretin
Origin:
EU

Neotigason (Acitretin)

Acitretin, the active ingredient in Neotigason, is a retinoid presented as an oral formulation for oral use. It is employed in the management of severe psoriasis and related keratinization disorders in adult patients.

GNH India supplies Neotigason as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Actavis Group Ptc Ehf.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Neotigason is a retinoid indicated for severe forms of psoriasis and related skin conditions.

  • Severe plaque psoriasis: reduces scaling, erythema and plaque thickness.
  • Psoriatic erythroderma: helps normalize epidermal turnover and improves skin appearance.
  • Generalized pustular psoriasis: controls acute pustular flares and promotes lesion clearance.

How It Works

  • Acitretin binds to nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), altering transcription of genes that regulate keratinocyte proliferation and differentiation. This modulation normalizes epidermal cell growth, reduces hyperkeratosis, and diminishes inflammatory signaling in psoriatic skin.

Side Effects

Acitretin may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dry skin and mucous membranes: dryness of lips, eyes and nasal passages.
  • Cheilitis: cracking and inflammation of the lips.
  • Elevated triglycerides: increase in blood lipid levels.
  • Headache: mild to moderate intensity.
  • Nausea: occasional gastrointestinal upset.
  • Hair thinning: temporary loss of scalp hair.

Serious or Rare Side Effects

  • Hepatotoxicity: liver enzyme elevation or liver injury.
  • Severe hyperlipidemia: marked increase in cholesterol or triglycerides.
  • Depression or mood changes: potential psychiatric effects.
  • Bone abnormalities: premature epiphyseal closure in children.
  • Pseudotumor cerebri: increased intracranial pressure.
  • Severe cutaneous reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

Before initiating therapy, several safety considerations are required.

  • Teratogenicity: avoid use in pregnancy and discontinue at least 3 years before conception.
  • Liver function: monitor hepatic enzymes regularly during treatment.
  • Lipid profile: assess serum triglycerides and cholesterol before and during therapy.
  • Bone health: avoid in patients with active bone disease or severe skeletal growth disorders.
  • Concomitant vitamin A: do not combine with other vitamin A derivatives to prevent toxicity.

Store at ambient temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Acitretin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Tetracyclines: increased risk of pseudotumor cerebri.
  • Vitamin A supplements: additive retinoid toxicity.
  • Systemic methotrexate: heightened hepatic injury risk.
  • Warfarin: possible alteration of anticoagulant effect.
  • Oral contraceptives: reduced hormonal efficacy, raising teratogenic risk.

Moderate Interactions (Monitor Closely)

  • Statins: potential for combined lipid abnormalities and liver stress.
  • Glucocorticoids: additive effects on lipid metabolism.
  • Enzyme‑inducing antiepileptics: may lower acitretin plasma concentrations.

Frequently Asked Questions

Neotigason contains acitretin, a retinoid prescribed for the treatment of severe psoriasis, including plaque, erythrodermic and pustular forms. It helps normalize skin cell growth and reduces scaling, redness, and plaque thickness in adult patients.

Acitretin binds to nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR), modifying gene expression that controls keratinocyte proliferation and differentiation. This results in a more regular epidermal turnover and less inflammatory skin lesions.

The specific dose of Neotigason is determined by the prescribing physician based on the severity of the disease, patient weight, and laboratory monitoring. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Neotigason is classified as pregnancy category X because it is highly teratogenic. It must not be used by pregnant women or women who may become pregnant, and effective contraception is required for at least three years after stopping therapy. Safety during breastfeeding has not been established, so it is generally avoided.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with biologic agents, acitretin is an oral systemic retinoid that does not require injection and has a different safety profile. It is useful for patients who prefer oral therapy or who have contraindications to biologics, but it carries risks of teratogenicity, liver toxicity and lipid abnormalities that require monitoring.

Neotigason should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency.

Neotigason is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not crushed or chewed. Administration is typically once daily, but the exact schedule is set by the prescribing clinician.

The most serious risks include severe birth defects if exposure occurs during pregnancy, hepatotoxicity, marked hyperlipidemia, and rare but severe skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored regularly for liver function, lipid levels and any signs of skin or psychiatric changes.

Neotigason is contraindicated in pregnant women, women planning pregnancy, and individuals with severe liver disease, uncontrolled hyperlipidemia, or active bone disorders. It should also be avoided in patients taking other systemic retinoids or high‑dose vitamin A supplements.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Acitretin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT